The diagnostic significance of serum levels of nerve growth factor and brain-derived neurotrophic factor in Diabetic Peripheral Neuropathy (DPN) | All the latest summaries on the portal Medznat.ru. :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

The diagnostic significance of serum levels of nerve growth factor and brain-derived neurotrophic factor in Diabetic Peripheral Neuropathy (DPN)

The diagnostic significance of serum levels of nerve growth factor and brain-derived neurotrophic factor in Diabetic Peripheral Neuropathy (DPN) The diagnostic significance of serum levels of nerve growth factor and brain-derived neurotrophic factor in Diabetic Peripheral Neuropathy (DPN)
The diagnostic significance of serum levels of nerve growth factor and brain-derived neurotrophic factor in Diabetic Peripheral Neuropathy (DPN) The diagnostic significance of serum levels of nerve growth factor and brain-derived neurotrophic factor in Diabetic Peripheral Neuropathy (DPN)

The study was conducted with an aim to discover BDNF and NGF levels in T2DM patients, healthy individuals and DPN) patients so as to find their effects on DPN.

See All

Key take away

The available treatment approaches for DPN only help in providing symptomatic relief and minimizing pain. However, the cure and nerve damage repair is not possible. This study depicted that increasing Nerve Growth Factor (NGF) level could protect against DPN. Also, an elevated Brain-Derived Neurotrophic Factor (BDNF) level is useful in DPN treatment. Future studies, specifically targetting mechanisms of NGF and BDNF levels on DPN are needed.

Background

The study was conducted with an aim to discover BDNF and NGF levels in T2DM patients, healthy individuals and DPN) patients so as to find their effects on DPN.

Method

The clinical data of a total of 110 healthy participants with age: 57.3±8.2 year, height: 165.4±5.5 cm, weight: 64.1±7.5 kg, 83 T2DM patients with age: 56.5±7.9 year, height: 164.8±6.2 cm, and weight: 63.6±6.6 kg, and 65 DPN patients with age: 58.2±7.3 year, height: 166.7±6.7 cm, weight: 63.1±5.8 kg were observed. ELISA was applied to identify the serum NGF and BDNF levels. To evaluate the diagnostic value of BDNF and NGF levels in DPN, receiver operating characteristic (ROC) curve analysis was executed. Logistic regression analysis was carried out to investigate risk factors for DPN.

Result

Serum NGF and BDNF levels are lower in most of the DPN patients. The authors determined that serum NGF and BDNF levels were associated with

Fasting C-peptide

Glycated hemoglobin (HbAlc)

Disease course for patients

2-hour postprandial C-peptide level

24-hour urinary microalbumin excretion.

High specificity, accuracy and sensitivity of BDNF and NGF levels on DPN were noted as per ROC analysis. Risk factors of DPN were the course of disease, postprandial blood glucose level, serum levels of NGF and BDNF and 2-h PCP level.

Conclusion

This study provides evidence on the possible connection of BDNF and NGF levels with the incidence and development of DPN.

Source:

Med Sci Monit. 2018 Aug 26;24:5943-5950

Article:

Diagnostic Significance of Serum Levels of Nerve Growth Factor and Brain Derived Neurotrophic Factor in Diabetic Peripheral Neuropathy

Authors:

Qin Sun et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: